U.S. flag

An official website of the United States government

NM_005327.7(HADH):c.*660_*661del AND Hyperinsulinemic hypoglycemia, familial, 4

Germline classification:
Likely benign (1 submission)
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003232910.1

Allele description [Variation Report for NM_005327.7(HADH):c.*660_*661del]

NM_005327.7(HADH):c.*660_*661del

Gene:
HADH:hydroxyacyl-CoA dehydrogenase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
4q25
Genomic location:
Preferred name:
NM_005327.7(HADH):c.*660_*661del
HGVS:
  • NC_000004.12:g.108035017_108035018del
  • NG_008156.2:g.50234_50235del
  • NG_008156.3:g.50130_50131del
  • NM_001184705.4:c.*660_*661del
  • NM_001331027.2:c.*660_*661del
  • NM_005327.7:c.*660_*661delMANE SELECT
  • NC_000004.11:g.108956173_108956174del
Molecular consequence:
  • NM_001184705.4:c.*660_*661del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001331027.2:c.*660_*661del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_005327.7:c.*660_*661del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]

Condition(s)

Name:
Hyperinsulinemic hypoglycemia, familial, 4 (HHF4)
Synonyms:
Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
Identifiers:
MONDO: MONDO:0012382; MedGen: C1864948; Orphanet: 71212; OMIM: 609975

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003929463Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
criteria provided, single submitter

(K & H Uppaluri Personalized Medicine Clinic Variant Classification & Assertion Criteria_Updated V.1)		Likely benignunknownresearch

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedresearch

Citations

PubMed

Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management.

Giri D, Hawton K, Senniappan S.

J Pediatr Endocrinol Metab. 2021 Sep 21;35(3):279-296. doi: 10.1515/jpem-2021-0369. Print 2022 Mar 28. Review.

PubMed [citation]
PMID:
34547194

Genotyping of ABCC8, KCNJ11, and HADH in Iranian Infants with Congenital Hyperinsulinism.

Hashemian S, Esfehani RJ, Karimdadi S, Ghaemi N, Eshraghi P, Gonabadi NM, Sahebkar A, Vakili R, Abbaszadegan MR.

Case Rep Endocrinol. 2021;2021:8826174. doi: 10.1155/2021/8826174.

PubMed [citation]
PMID:
34055426
PMCID:
PMC8137283
See all PubMed Citations (3)

Details of each submission

From Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic, SCV003929463.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (3)

Description

Potent mutations in HADH gene are associated with congenital hyperinsulinism, which leads to recurrent hypoglycemia. The condition is exacerbated by stress, fasting or excessive dietary protein. May respond well to diazoxide. However, the role of this particular variant rs886058981 in congenital hyperinsulinism is yet to be ascertained.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2023